An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod von Hesselstrand, Roger, Distler, Joerg H. W., Riemekasten, Gabriela, Wuttge, Dirk M., Torngren, Marie, Nyhlen, Helen C., Andersson, Fredrik, Eriksson, Helena, Sparre, Birgitta, Tuvesson, Helen, Distler, Oliver

Volltext

An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod von Hesselstrand, Roger, Distler, Jörg H W, Riemekasten, Gabriela, Wuttge, Dirk M, Törngren, Marie, Nyhlén, Helén C, Andersson, Fredrik, Eriksson, Helena, Sparre, Birgitta, Tuvesson, Helén, Distler, Oliver

Volltext

Naptumomab Estafenatox, an Engineered Antibody-superantigen Fusion Protein With Low Toxicity and Reduced Antigenicity von FORSBERG, Göran, SKARTVED, Niels-Jörgen, WALLEN-ÖHMAN, Marie, NYHLEN, Helen Carlsson, BEHM, Kristina, HEDLUND, Gunnar, NEDERMAN, Thore

Volltext